NCT04763512View on ClinicalTrials.gov

Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 6, 2021

Primary Completion Date

September 19, 2023

Study Completion Date

November 2, 2024

Conditions
Atopic DermatitisSkin Condition
Interventions
DIETARY_SUPPLEMENT

Intact Cow's Milk Protein Formula

Study product will be provided as powder, reconstituted with water by parents/caregivers according to label instructions, and consumed orally. Study participants will continue this feeding regimen for 4 months.

DIETARY_SUPPLEMENT

Partially Hydrolysed Whey Formula

Study product will be provided as powder, reconstituted with water by parents/caregivers according to label instructions, and consumed orally. Study participants will continue this feeding regimen for 16 months.

Trial Locations (1)

Unknown

Shanghai Tonxin Pediatric Clinic Co. Ltd, Shanghai

Sponsors
All Listed Sponsors
collaborator

Medidata Solutions

INDUSTRY

collaborator

SAS Institute

INDUSTRY

collaborator

Veeva Systems

INDUSTRY

collaborator

Cognizant Technology Solutions AG

UNKNOWN

lead

Société des Produits Nestlé (SPN)

INDUSTRY